BAX - BAXTER INTERNATIONAL INC

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 35.95

Open

$ 35.74

Bid

$ 35.89 x 100

Ask

$ 39.48 x 100

Day's Range

$ 35.58 - $ 35.94

52 Week Range

$ 30.55 - $ 49.12

Volume

4,997,710

Average Volume

Market Cap

18.33B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

$ 6.92

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.03)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-08-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	07-27-2023	06-30-2023	10-Q
5	04-27-2023	03-31-2023	10-Q
6	02-09-2023	12-31-2022	10-K
7	10-27-2022	09-30-2022	10-Q
8	07-28-2022	06-30-2022	10-Q
9	04-28-2022	03-31-2022	10-Q
10	02-23-2022	12-31-2021	10-K
11	10-28-2021	09-30-2021	10-Q
12	07-29-2021	06-30-2021	10-Q
13	04-29-2021	03-31-2021	10-Q
14	02-11-2021	12-31-2020	10-K
15	10-29-2020	09-30-2020	10-Q
16	07-30-2020	06-30-2020	10-Q
17	04-30-2020	03-31-2020	10-Q
18	03-17-2020	09-30-2019	10-Q
19	03-17-2020	12-31-2019	10-K
20	07-30-2019	06-30-2019	10-Q
21	05-08-2019	03-31-2019	10-Q
22	02-21-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-06-2018	06-30-2018	10-Q
25	05-09-2018	03-31-2018	10-Q
26	02-23-2018	12-31-2017	10-K
27	11-02-2017	09-30-2017	10-Q
28	08-07-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	02-23-2017	12-31-2016	10-K
31	11-07-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-06-2016	03-31-2016	10-Q
34	02-26-2016	12-31-2015	10-K
35	11-09-2015	09-30-2015	10-Q
36	08-07-2015	06-30-2015	10-Q
37	05-06-2015	03-31-2015	10-Q
38	02-26-2015	12-31-2014	10-K
39	10-29-2014	09-30-2014	10-Q
40	07-30-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

why-is-medical-device-maker-baxter-stock-trading-lower-on-thursday

Why Is Medical Device Maker Baxter Stock T...
05/02/2024 19:12:08

Baxter reports Q1 adjusted EPS at $0.65, up 10% Y/Y, surpassing expectations. Sales hit $3.59 billion, with 2% growth on a repo...

10-health-care-stocks-whale-activity-in-todays-session

10 Health Care Stocks Whale Activity In To...
05/02/2024 17:35:24

Baxter International Sees Q2 2024 Adj. EPS...
05/02/2024 11:20:52

Baxter International Sees FY24 Adj. EPS $2...
05/02/2024 11:20:42

Baxter Intl Q1 2024 Adj EPS $0.65 Beats $0...
05/02/2024 11:16:33

Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.65 per share which beat the analyst consensus estimate of $0.61 by 6.5...

Baxter Expands Pharmaceuticals Portfolio W...
04/11/2024 12:32:06

Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfol...

Assessing Baxter Intl: Insights From 4 Fin...
04/03/2024 16:00:53

Citigroup Maintains Neutral on Baxter Intl...
04/03/2024 15:34:06

Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $41 to $44.

medical-devices-giant-baxter-secures-fda-approval-for-new-infusion-pump-system

Medical Devices Giant Baxter Secures FDA A...
04/01/2024 16:38:56

FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducin...

Baxter Announces US FDA Clearance of Novum...
04/01/2024 11:16:07

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food an...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/20/2024 17:35:24

why-are-dialysis-provider-stocks-trading-higher-on-tuesday

Why Are Dialysis Provider Stocks Trading H...
03/05/2024 20:21:24

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with sema...

B of A Securities Maintains Neutral on Bax...
03/05/2024 14:39:06

B of A Securities analyst Travis Steed maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $42 ...

Spectral Medical Announces Amendment And E...
02/21/2024 21:02:33

Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a late-stage theranostic company advancing thera...

Barclays Maintains Overweight Rating for B...
02/12/2024 17:00:30

JP Morgan Maintains Neutral on Baxter Intl...
02/09/2024 19:58:57

JP Morgan analyst Robbie Marcus maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $38 to $44.

baxter-says-2023-performance-reflects-strategic-initiatives-with-new-operating-model-without-biopharma-solutions-unit

Baxter Says 2023 Performance Reflects Stra...
02/08/2024 17:51:52

Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, The...

Baxter Forecasts FY24 Adjusted EPS Of $2.8...
02/08/2024 12:20:20

Baxter Forecasts Q1 FY24 Adjusted EPS Of $...
02/08/2024 12:19:10

Baxter Intl Q4 Adjusted EPS $0.88 Beats $0...
02/08/2024 12:16:48

Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.86 by 2.3...